- Home » News and EventsPage 2
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in technologies, expertise and capacity. Upcoming conferences and events.
Catalent Completes Accucaps Acquisition To Expand Softgel Development And Manufacturing Capabilities And Capacity
Feb 16, 2017
Catalent Pharma Solutions today announced that it has completed the acquisition of Accucaps Industries Limited (Accucaps).
Catalent Acquires Accucaps To Expand Softgel Development And Manufacturing Capabilities And Capacity
Nov 28, 2016
Catalent Pharma Solutions today announced that it has agreed to acquire Accucaps Industries Limited (Accucaps).
Catalent Expert To Present Innovative Softgel Developments To Improve Product Performance And Brand Awareness At OTC Conference In Singapore
Oct 19, 2016
Catalent Pharma Solutions today announced that Ms. Humera Ahmad, Director of Product Development, Softgel – Asia-Pacific, will be presenting at the upcoming Nicholas Hall Asia-Pacific OTC Conference.
Catalent Wins Prestigious CPhI Pharma Award For OptiForm® Solution Suite Platform At CPhI Worldwide
Oct 5, 2016
Catalent Pharma Solutions today announced that its OptiForm® Solution Suite and OptiForm® Solution Suite Bio platforms have won the ‘Excellence in Pharma: Contract Services and Outsourcing’ award.
Catalent Announces Appointment Of Stephen Vanni As New General Manager Of Braeside, Australia, Facility
Jul 5, 2016
Catalent Pharma Solutions today announced the appointment of Stephen Vanni as General Manager of the company’s Braeside facility in Melbourne, Australia.
OPKO’s Rayaldee® Product Receives FDA Approval – Uses Catalent’s OptiShell® Capsule Technology As Delivery Platform
Jun 21, 2016
Catalent Pharma Solutions welcomed OPKO Health, Inc.’s (NYSE: OPK) announcement that its New Drug Application (NDA) for RAYALDEE® has been approved by the US Food and Drug Administration (FDA).
Catalent Wins Prestigious ‘Editor’s Choice’ Award At Interphex For Its OptiForm® Solution Suite Platform
Apr 26, 2016
Catalent Pharma Solutions today announced that it has won the ‘Editor’s Choice’ category at the annual INTERPHEX Awards, for its OptiForm® Solution Suite platform.
Overcoming Bioavailability Challenges Through Particle-size Engineering To Be Presented At Upcoming CPhI Japan Conference By Catalent Expert
Apr 13, 2016
Catalent Pharma Solutions today announced that Mr. Arnaud Bathelier, Catalent Micron Technologies, will be presenting at the upcoming CPhI Japan Conference.
Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent
Dec 7, 2015
Catalent Pharma Solutions today announced that it has entered into an exclusive long term supply agreement to produce Pfizer Inc.’s leading over-the-counter (OTC) heartburn treatment, Nexium® 24HR.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.